25/09/2019
Collaborative work with experimenters from AstraZeneca pharmaceutical company entitled «Using Quantitative Systems Pharmacology modeling to predict response and resistance of immune checkpoint inhibitors (ICI) in murine syngeneic tumors» (Poster B154) was presented by Kirill Peskov and Ivan Azarov. The main message of this work was that the mechanistic quantitative immuno-oncology model demonstrated its suitability for predicting tumor size dynamics in response to various immune inhibitors for several syngeneic tumors.
